CSIMarket
 
Pfizer Inc  (NYSE: PFE)
 

Pfizer Inc's Suppliers Performance

PFE's Supply Chain




 
PFE Costs vs Sales of Suppliers Growth Pfizer Inc's Suppliers recorded an increase in sales by 8.77 % year on year in Q3 2026, sequentially sales grew by 36.8 %, Pfizer Inc's cost of sales deteriorated by -3.45 % year on year, relative to one quarter ago cost of sales fell by -1.56 % in Q3.

• More on PFE Suppliers



Pfizer Inc's Suppliers recorded an increase in sales by 8.77 % year on year in Q3 2026, sequentially sales grew by 36.8 %, Pfizer Inc's cost of sales deteriorated by -3.45 % year on year, compare to one quarter ago cost of sales fell by -1.56 % in Q3.

• More on PFE Suppliers




Pfizer Inc's Comment on Supply Chain


Raw materials essential to our businesses are purchased worldwide in the ordinary course of business from numerous suppliers. In general, these materials are available from multiple sources. We have successfully secured the materials necessary to meet our requirements where there have been short-term imbalances between supply and demand, but generally at higher prices than those historically paid.

Pfizer Inc's Comment on Supply Chain


Raw materials essential to our businesses are purchased worldwide in the ordinary course of business from numerous suppliers. In general, these materials are available from multiple sources. We have successfully secured the materials necessary to meet our requirements where there have been short-term imbalances between supply and demand, but generally at higher prices than those historically paid.


PFE's Suppliers Net profit fell by PFE's Suppliers Net margin fell in Q3 to
-21.08 % 5.85 %
PFE's Suppliers Net profit fell by -21.08 %


PFE's Suppliers Net margin fell in Q3 to 5.85 %


Pfizer Inc's Suppliers Sales Growth in Q3 2026 by Industry

Suppliers from Chemical Manufacturing Industry -26.75 %   
Suppliers from Chemicals - Plastics & Rubber Industry      8.31 %
Suppliers from Paper & Paper Products Industry      5.24 %
Suppliers from Industrial Machinery and Components Industry      4.36 %
Suppliers from Personal & Household Products Industry      1.05 %
Suppliers from Major Pharmaceutical Preparations Industry      13.54 %
Suppliers from Communications Equipment Industry      18.41 %
Suppliers from Internet Services & Social Media Industry      9.02 %
Suppliers from Scientific & Technical Instruments Industry      9.13 %
     





PFE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Pfizer Inc 168,849.36 63,625.00 4,062.00 75,000
Abbvie Inc 520,773.08 66,014.00 10,346.00 57,000
Alpha Cognition Inc. 190.09 15.26 -24.00 0
Amneal Pharmaceuticals Inc 7,177.97 3,196.18 175.49 8,500
Bio Green Med Solution Inc 4.49 1.86 -13.23 19
Biogen Inc 37,430.35 10,297.30 347.50 7,500
SUBTOTAL 3,872,924.27 897,383.12 62,973.59 1,528,560
64 more Suppliers available

Sign in to see all suppliers for Pfizer Inc.



Sources: Pfizer Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Pfizer Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.